Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation

Autor:	Mindy Landau, Jean A. Yared, S Hajj, Zeba N. Singh, A. Badros, Saul Yanovich, C Goecke, Nancy M. Hardy, Edward A. Sausville, Mehmet H. Kocoglu, Kathleen Ruehle, C Ujjani, Aaron P. Rapoport
Rok vydání:	2016
Předmět:	0301 basic medicine Oncology medicine.medical_specialty medicine.medical_treatment Programmed Cell Death 1 Receptor Hematopoietic stem cell transplantation 03 medical and health sciences 0302 clinical medicine Imaging Three-Dimensional immune system diseases hemic and lymphatic diseases Internal medicine Refractory Hodgkin Lymphoma Medicine Humans Transplantation Homologous Progenitor cell Transplantation business.industry Hematopoietic Stem Cell Transplantation Antibodies Monoclonal Hematology Immunotherapy Middle Aged medicine.disease Hodgkin Disease 030104 developmental biology Graft-versus-host disease Nivolumab Treatment Outcome 030220 oncology & carcinogenesis Positron-Emission Tomography Immunology Disease Progression Female Stem cell Neoplasm Recurrence Local business
Zdroj:	Bone marrow transplantation. 51(6)
ISSN:	1476-5365
Popis:	Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536a8e85404f206e1cd0aad98da8e4bd https://pubmed.ncbi.nlm.nih.gov/26828905 Zobrazit plný text záznamu Full text from SpringerLink